Afrigen

Afrigen is a biotechnology company headquartered in Cape Town, South Africa, with a focus on vaccine research and manufacturing-capacity development. During the COVID-19 pandemic, it participated in mRNA vaccine technology transfer and localization efforts intended to strengthen vaccine research, technology access, and manufacturing capabilities in South Africa and elsewhere in Africa. The available material is insufficient to confirm its complete corporate history, commercial product portfolio, ownership structure, or latest operating status.

Afrigen is headquartered in Cape Town, South Africa, and focuses on biotechnology activities related to vaccine research and manufacturing-capacity development. During the COVID-19 pandemic, the company participated in mRNA vaccine technology-transfer and localization work intended to support more self-reliant vaccine research and manufacturing capacity in Africa. Because verified public information is limited, its founding year, early activities, organizational changes, and later commercialization progress are not stated here.